Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer

International Journal of Cancer

Volumn 69, Issue 1, 1996, Pages 23-27

  Seshadri, Ram ^a,c   Mcleay, William R B ^a   Horsfall, David J ^a   Mccaul, Kieran ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b South Australian Health Commission   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0029930644     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960220)69:1<23::AID-IJC5>3.0.CO;2-Y     Document Type: Article

References (15)

1. ALTMAN, D.G., LAUSEN, B., SAUERBREI, W. and SCHUMAKER, M., Dangers of using "optimal" outpoints in the evaluation of prognostic factors. J. nat. Cancer Inst., 86, 829-835 (1994).
2. BLOOM, H.J. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. Brit J. Cancer, 11, 359-377 (1957).
3. COX, D.R. and HINKLEY, D.V., Theoretical statistics, pp. 314-317, Chapman and Hall, London (1974).
4. HILSENBECK, S.G., CLARK, G.M. and MCGUIRE, W.L., Why do so many prognostic factors fail to pan out? Breast Cancer Res. Treat., 22, 197-206 (1992).
5. HORSFALL, D.J., TILLEY, W.D., ORELL, S.R., MARSHALL, V.R. and CANT, E.L.M., Relationship between ploidy and steroid hormone receptors in primary breast cancer. Brit. J. Cancer, 53, 23-28 (1986).
6. KLIJN, J.G.M., BERNS, P.M.J.J., SCHMITZ, P.I.M. and FOEKENS, J.A., The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5,232 patients. Endocrinol. Rev., 13, 3-17 (1992).
7. KLIJN, J.G.M., LOOK, M.P., PORTENGEN, H., ALEXIEVA-FIGUSCH, J., VAN PUTTEN, W.L. and FOEKENS, J.A., The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study. Breast Cancer Res. Treat., 29, 73-83 (1994).
8. KOENDERS, P.G., BEEX, I.V., KIENHUIS, C.B., KLOPPENBORG, P.W. and BENRAAD, T.J., Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study. Breast Cancer Res. Treat., 25, 21-27 (1993).
9. MCLEAY, W.R.B., HORSFALL, D.J., SESHADRI, R., MORRISON, D.A. and SACCONE, G.T.P., Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors. Breast Cancer Res. Treat., 22, 141-151 (1992).
10. NICHOLSON, S., SAINSBURY, J.R.C., HALCROW, P., KELLEY, P., ANGUS, B., WRIGHT, C., HENRY, J., FARNDON, J.R. and HARRIS, A.L., Epidermal growth factor receptor (EGF-r); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Brit. J Cancer, 63, 146-150 (1991).
11. NICHOLSON, S., WRIGHT, C., SAINSBURY, J.R.C., HALCROW, P., KELLEY, P., ANGUS, B., HENRY, J., FARNDON, J.R. and HARRIS, A.L., Epidermal growth factor receptor (EgfR) as a marker for poor prognosis in node negative breast cancer patients. Neu and tamoxifen failure. J. Steroid Biochem. mol. Biol., 37, 811-814 (1990).
12. OSBORNE, C.K., Prognostic factors for breast cancer: have they met their promise? J. clin. Oncol., 10, 679-682 (1992).
13. PIETRAS, R., ARBOLEDA, J., REESE, D., WONGVIPAT, N., PEGRAM, M.D., RAMOS, L., GORMA, C.M., PARKER, M., SLIWKOWSKI, M.X. and SLAMON, D.J., HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-2446 (1995).
14. PRESS, M., HUNG, G., GODOLPHIN, W. and SLAMON, D., Sensitivity of HER-2/neu oncogene antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. Cancer Res, 54, 2771-2777 (1994).
15. SHARMA, A.K., HORGAN, K., DOUGLAS-JONES, A., MCCLELLAND, R., GEE, J. and NICHOLSON, R. Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Brit. J Cancer, 69, 1032-1037 (1994).